Economic Medical Evaluation of Treatment of the Neuropathic Pain Rebel by Cortical Stimulation

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00241566

Enrollment

200

Registered

2005-10-19

Start date

2003-08-31

Completion date

2007-12-31

Last updated

2010-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuropathic Pain Rebel

Keywords

Neuropathic pain, Electric cortical stimulation, Economic Medical evaluation

Brief summary

All neuropathic chronicle pains are difficult to treat. Currently many patients are not relieved by electric stimulations of central nervous system, existing. Recently cortical stimulation had a development important and benefit effects are proven. In this study we evaluate medico-economic impact of this treatment.

Interventions

DEVICEimplantation of stimulator

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Presence of pain caused by lesion of central or peripheral nervous system * Pain persistent since one year at least * Pain untreated with 3 different antalgic treatments

Exclusion criteria

* Pain linked t a malignant affection * patient \< 18 years-old

Design outcomes

Primary

Measure	Time frame
Cost of treatment of this pathology	—

Secondary

Measure	Time frame
Evaluation of the pain when the electric stimulation is off or on (during one month for each one). Using Visual Analogic Scale.	—

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026